Grafapex Injection, Powder, Lyophilized, For Solution
Product Images NDC 59137-365

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Grafapex (NDC 59137-365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medexus Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Treosulfan Chemical Structure (Chemical Structure)

Treosulfan Chemical Structure (Chemical Structure)
Chemical structure diagram depicting the molecular structure of treosulfan, the active ingredient in GRAFAPEX injection, powder, lyophilized, for solution. The diagram shows atoms and bonds typical of treosulfan's chemical formula.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A Kaplan-Meier overall survival graph comparing Busulfan and Treosulfan treatments over 54 months. The y-axis shows the overall survival rate from 0 to 1, and the x-axis shows time in months. Treosulfan displays a higher survival rate than Busulfan throughout the period. The chart includes patient numbers, events, censored data, hazard ratio (0.67), and confidence interval (0.51 to 0.90), with patients at risk listed below the timeline.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A Kaplan-Meier overall survival rate curve comparing Treosulfan and Busulfan over a time period up to 54 months. The graph includes patient numbers at risk at various time points, events, censored data, hazard ratio, and confidence intervals. Treosulfan shows a higher survival rate compared to Busulfan throughout the timeline.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A Kaplan-Meier survival curve comparing overall survival rates over time in months between two patient groups treated with Busulfan and Treosulfan. The chart includes the number of patients, events, censored cases, hazard ratio, and 95% confidence interval for each treatment. It also displays the number of patients at risk at various time points up to 54 months.*
FDA Label Image

Grafapex 1g Carton (Grafapex Carton 1g)

Grafapex 1g Carton (Grafapex Carton 1g)
Packaging label for GRAFAPEX (treosulfan) Injection powder, lyophilized, for intravenous use, 1 g/vial. The label includes storage instructions, usage warnings, and dosage information. Labeler is Medexus Pharma, Inc., manufactured by Oncotec Pharma Produktion GmbH in Germany, with product origin Finland. The label features the NDC 59137-335-01 and a barcode.*
FDA Label Image

Grafapex 5g Carton (Grafapex Carton 5g)

Grafapex 5g Carton (Grafapex Carton 5g)
Box packaging label for GRAFAPEX (treosulfan) for Injection, Powder, Lyophilized, for solution, 5 g/vial. It is manufactured for Medexus Pharma, Inc. and by Oncotec Pharma Produktion GmbH in Germany. The label includes storage instructions, intravenous route, and dosage information, with warnings that it is a hazardous drug and single-dose vial only.*
FDA Label Image

Grafapex 1g Vial (Grafapex Vial 1g)

Grafapex 1g Vial (Grafapex Vial 1g)
Label for GRAFAPEX (treosulfan) injection, powder, lyophilized for solution, 1 g per vial. The label indicates use for intravenous infusion after reconstitution, includes a hazardous drug warning, single-dose vial instruction, and storage temperature requirements. Manufactured for Medexus Pharma, Inc., Chicago, Illinois, and by Oncotec Pharma Produktion GmbH, Germany.*
FDA Label Image

Grafapex 5g Vial (Grafapex Vial 5g)

Grafapex 5g Vial (Grafapex Vial 5g)
Label for GRAFAPEX treosulfan for Injection 5 g/vial, lyophilized powder for intravenous infusion after reconstitution. It is a single-dose vial labeled as a hazardous drug. Manufactured for Medexus Pharma, Inc., Chicago, and by Oncotec Pharma Produktion GmbH, Germany. Includes storage instructions and cautions to discard unused portions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.